Overview

Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine

Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Effectivity and safety of PFO closure vs medicine in alleviating migraine （SPRING）: a multicenter, random, case control study
Phase:
Phase 3
Details
Lead Sponsor:
Guangdong Provincial People's Hospital
Treatments:
Aspirin
Clopidogrel